MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for COPD & Lung Disease

How Stem Plus applies MSCs from Amniotic Membrane within a personalised COPD & Lung Disease protocol — in the EU, from €3,000–€8,000.

For COPD & Lung Disease, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for COPD & Lung Disease. Compare them on the COPD & Lung Disease overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

Terapie celulară de nivel european, fără prețuri europene.

Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.

Evaluare medicală gratuită